Tue, October 1, 2024
Mon, September 30, 2024
Fri, September 27, 2024
Thu, September 26, 2024
Wed, September 25, 2024
Tue, September 24, 2024

Ed Arce Maintained (TVTX) at Strong Buy with Decreased Target to $18 on, Sep 27th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-18-on-sep-27th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ed Arce of HC Wainwright & Co., Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Decreased Target from $23 to $18 on, Sep 27th, 2024.

Ed has made no other calls on TVTX in the last 4 months.



There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 1 agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Allison Bratzel of "Piper Sandler" Maintained at Hold with Increased Target to $12 on, Friday, August 2nd, 2024


These are the ratings of the 4 analyists that currently disagree with Ed


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Friday, September 13th, 2024
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $23 on, Tuesday, September 10th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $16 on, Friday, August 2nd, 2024
  • Carter Gould of "Barclays" Maintained at Buy with Increased Target to $14 on, Friday, August 2nd, 2024

Publication Contributing Sources